While proteomics has been the darling of private investors for several years, governments in the US and in Europe are now getting ready to open their checkbooks to large-scale proteomics research as well. At this time, scientists in the US are crossing their fingers for favorable funding decisions. Meanwhile, their colleagues across the Atlantic are forming alliances to apply for EU funding later this year.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.